TITLE

Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study

AUTHOR(S)
Heidari, Ramin; Sadeghi, Masoumeh; Talaei, Mohammad; Rabiei, Katayoun; Mohammadifard, Noushin; Sarrafzadegan, Nizal
PUB. DATE
January 2010
SOURCE
Diabetology & Metabolic Syndrome;2010, Vol. 2 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: There is a remarkable increase in cardiovascular disease after menopause. On the other hand, metabolic syndrome as a collection of risk factors has a known effect on cardiovascular diseases. Hormone changes are considered as one of the main relevant factor regarding cardiovascular disease as well as some recognized relationship with metabolic syndrome's components. This study was carried out in order to search for prevalence of metabolic syndrome during menopausal transition. Method: In a cross sectional study in urban and rural areas of Isfahan, Najafabad and Arak cities, 1596 women aged more than 45 years were investigated using Isfahan Healthy Heart Program's (IHHP) samples. Participants were categorized into three groups of pre-menopause, menopause and post-menopause. Leisure time physical activity and global dietary index were included as life style factors. The association of metabolic syndrome and its components with menopausal transition considering other factors such as age and life style was analyzed. Results: there were 303, 233 and 987 women in premenopausal, early menopausal and postmenopausal groups respectively. Metabolic syndrome was found in 136(44.9%) premenopausal participants and significantly increased to 135(57.9%) and 634(64.3%) in early menopausal and postmenopausal participants respectively, when age was considered (P = 0.010). Except for hypertension and hypertriglyceridemia, there was no significant difference between three groups of menopausal transition when metabolic syndrome's components were considered. Conclusion: In contrary to the claims regarding the role of waist circumference and blood glucose in increasing of metabolic syndrome during the menopausal transition, this study showed this phenomenon could be independence of them.
ACCESSION #
64934415

 

Related Articles

  • Síndrome metabólico en menopausia: implicaciones de la terapia hormonal. Tabares-Trujillo, María Katherine; Aguilera-Pérez, Jesús Rafael; Velázquez-Valassi, Beatriz; Garza-Ríos, Pablo; Citlalli Angulo-Torres, Lizbeth; García-Ruiz, Rosalía // Perinatologia y Reproduccion Humana;ene-mar2012, Vol. 26 Issue 1, p25 

    Introduction: The incidence of cardiovascular disease and metabolic syndrome during the menopause is around 35%. The objective of this study was to establish the relation between anthropometric and biochemical values in those patients with metabolic syndrome with and without hormone replacement...

  • UTICAJ TRAJANJA MENOPAUZE, ANTROPOMETRIJSKIH I HORMONSKIH PARAMETARA NA METABOLIÄŒKI SINDROM. SIMONCIG-NETJASOV, Aleksandra; VUJOVIĆ, Svetlana; IVOVIĆ, Miomira; TANČIĆ-GAJIĆ, Milina; DREZGIĆ, Milka // Medicinski Pregled / Medical Review;2010, Vol. 63 Issue 1/2, p33 

    No abstract available.

  • Menopause versus aging: The predictor of obesity and metabolic aberrations among menopausal women of Karnataka, South India. Dasgupta, Shruti; Salman, Mohammed; Lokesh, S.; Xaviour, D.; Saheb, S. Yaseen; Prasad, B. V. Ravi; Sarkar, Biswanath // Journal of Mid-life Health;Jan-Jun2012, Vol. 3 Issue 1, p24 

    Context: Increased incidences of cardiovascular disorder and metabolic syndrome particularly after menopause have raised curiosity for the underlying factors. However, it is still a debate whether age or menopausal transition is a greater contributor. Aims: To elucidate the inter-relationships...

  • Menopause And Metabolic Syndrome.  // Nutrition Health Review: The Consumer's Medical Journal;2009, Issue 100, p15 

    The article reports on a study which explores the prevalence of metabolic syndrome on women from premenopausal to postmenopausal stage. It notes that cardiovascular disease (CVD) often accelerates after menopause. Moreover, it cites that metabolic syndrome, despite the patient's age, increases...

  • The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health. Oben, Julius; Enonchong, Ebangha; Kuate, Dieudonne; Mbanya, Dora; Thomas, Tiffany C.; Hildreth, DeWall J.; Ingolia, Thomas D.; Tempesta, Michael S. // Lipids in Health & Disease;2007, Vol. 6, p20 

    Background: Metabolic Syndrome, or Syndrome X, is characterized by a set of metabolic and lipid imbalances that greatly increases the risk of developing diabetes and cardiovascular disease. The syndrome is highly prevalent in the United States and worldwide, and treatments are in high demand....

  • DETECTING AND MANAGING METABOLIC SYNDROME: A FEASIBILITY STUDY IN A GENERAL MEDICINE CLINIC. De la Rosa, Alexandra; Tahsin, Bettina; Sanghani, Roshani; Pikelny, Iry; Fogelfeld, Leon; Stroger Jr., John H. // Ethnicity & Disease;Spring2008 Supplement1, Vol. 18, pS1:6 

    Metabolic syndrome is a constellation of risk factors associated with increased cardiovascular and diabetes risk. Clinical research indicates that lifestyle changes can dramatically modify and even reverse all factors of metabolic syndrome. This study examines the feasibility of lifestyle...

  • The relation of metabolic syndrome according to five definitions to cardiovascular risk factors - a population-based study. Cheng-Chieh Lin; Chiu-Shong Liu; Chia-Ing Li; Wen-Yuan Lin; Ming-May Lai; Tsann Lin; Pei-Chia Chang; Yih-Dar Lee; Ching-Chu Chen; Chih-Hsueh Lin; Chuan-Wei Yang; Chih-Yi Hsiao; Chen, Walter; Tsai-Chung Li // BMC Public Health;2009, Vol. 9 Issue 1, p484 

    Background: Although National Cholesterol Education Program (NCEP), International Diabetes Federation (IDF), American Heart Association and National Heart, Lung and Blood Institute (AHA/NHLBI), World Health Organization (WHO), and the European Group for the Study of Insulin Resistance (EGIR)...

  • Hormone therapy for younger women may not increase CHD risk during 5-7 years follow-up, but stroke risk was increased independent of age.  // Evidence Based Medicine;Oct2007, Vol. 12 Issue 5, p137 

    The article presents the author's perspective on the study "Postmenopausal hormone therapy (HT) and risk of cardiovascular disease by age and years since menopause." The author contends that the study showed that no justification exist for initiation of HT in older asymptomatic women as a...

  • LOW TESTOSTERONE ASSOCIATED WITH HIGHER VASCULAR RISK.  // Life Extension;May2014, p5 

    The article focuses on the link between testosterone levels and aging in men.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics